The Legislative Framework for Ultrafine Particles in Europe
  • Blog

Invisible to the naked eye, yet increasingly on the radar of policymakers, ultrafine particles (UFPs) are quietly shaping the future of air quality regulations. As emerging science sheds light on their health impacts, governments worldwide are grappling with how to address this silent pollutant. But what does current legislation in Europe look like, and is it enough to protect us from these microscopic invaders?
Shutterstock Image

Introduction

Ultrafine particles (UFPs), defined as particles less than 0.1 microns in size, are increasingly becoming a focal point in discussions about air quality and public health. These particles, stemming from both natural processes and human activities such as transportation and industrial emissions, pose significant health risks that necessitate focused monitoring and mitigation efforts. This article describes the legislative framework surrounding UFPs in Europe, highlighting the importance of measuring this new metric, the WHO recommendations, and the detailed legislative activities undertaken by the European Commission, Parliament, and Council. We will also discuss the current status and future steps in the legislative process.

Importance of Measuring Ultrafine Particles and Health Impacts
Ultrafine particles (UFPs) present a unique and serious threat to human health due to their diminutive size and ability to carry toxic compounds. Unlike larger particles that are typically trapped in the upper respiratory tract, UFPs can penetrate deep into the lungs, reaching the alveoli and entering the bloodstream, where they can impact various organs, including the heart and brain.
The health risks associated with UFPs are significant and multifaceted. These particles can cause oxidative stress, inflammation, and cellular damage due to their large surface area and reactive properties. UFPs are also capable of carrying other pollutants, such as heavy metals and polycyclic aromatic hydrocarbons, further increasing their toxicity (Hinds, 1999). Epidemiological studies have linked exposure to UFPs with a range of adverse health effects, including respiratory and cardiovascular diseases, neurodevelopmental disorders, and even cancer (Zhang et al., 2010). Additionally, UFPs can exacerbate chronic respiratory conditions, trigger asthma, and heighten the risk of cardiovascular events like heart attacks and strokes. Emerging research also points to potential impacts on the nervous system, with possible links to neurodegenerative diseases (Sioutas, 2005).

Limitations of Traditional Measurements
Traditional mass-based techniques, such as gravimetric analysis and light scattering, focus on the mass of particles like PM2.5, often overlooking ultrafine particles (UFPs) due to their minimal contribution to total mass (Zhang et al., 2010). This can lead to an incomplete assessment of air quality and health risks, as UFPs are often undetected. Given that UFPs have different sources, behaviors, and health impacts, there is a growing consensus that the number concentration of these particles may be a more relevant metric for assessing air quality and health risks (RI-URBANS, 2021). This necessitates a shift in monitoring strategies to include UFPs, ensuring a more comprehensive understanding of air pollution and its health impacts.

WHO Recommendations

Summary of WHO Guidelines Related to Ultrafine Particles
The World Health Organization (WHO) has long been a leader in providing guidelines for air quality standards that protect public health. Recognizing the growing evidence of the harmful effects of ultrafine particles (UFPs), the WHO has recommended more stringent measures to monitor and control these pollutants. Although specific guidelines for UFPs are still under development, the WHO has acknowledged their significant health impacts and has urged for increased research and monitoring efforts (WHO, 2021).

Key Points and Recommendations for Monitoring and Controlling Ultrafine Particles

  • 1. Enhanced Monitoring: The WHO emphasizes the need for enhanced monitoring of UFPs. This includes developing standardized methods for measuring particle number concentration and size distribution. Accurate and consistent monitoring is essential for understanding the exposure levels and health impacts of UFPs.
  • 2. Research and Evidence Gathering: To address the gaps in knowledge regarding UFPs, the WHO calls for comprehensive epidemiological and toxicological studies. These studies should focus on the sources, behavior, and health effects of UFPs, providing a solid evidence base for future guidelines and regulations.
  • 3. Public Health Interventions: The WHO recommends implementing public health interventions to reduce exposure to UFPs. This includes improving air filtration systems, promoting the use of cleaner technologies, and encouraging behavioral changes that reduce emissions of ultrafine particles.
  • 4. Policy Development: The WHO encourages governments and regulatory bodies to develop and enforce policies that limit the emission of UFPs from key sources such as traffic, industry, and residential heating. These policies should be integrated into broader air quality management strategies to ensure comprehensive protection of public health.
  • 5. International Collaboration: Given the transboundary nature of air pollution, the WHO stresses the importance of international collaboration. Countries should work together to share data, research findings, and best practices for monitoring and controlling UFPs. This collaborative approach will enhance the global response to the challenges posed by ultrafine particles.

Implementation of WHO Recommendations in Europe
The European Union (EU) has taken significant steps to align its air quality policies with WHO recommendations. This includes funding projects like the RI-URBANS initiative, which aims to improve air pollution monitoring systems across Europe, with a specific focus on UFPs. By developing innovative tools and methods, the EU seeks to enhance the understanding of UFP sources, exposures, and health effects, ultimately leading to more effective air quality management and public health protection (RI-URBANS, 2021).

European Legislation Process for Ultrafine Particles

European Commission Proposal
The European Commission has been at the forefront of the legislative process for addressing ultrafine particles (UFPs) within the EU. Recognizing the limitations of existing air quality standards, which primarily focus on larger particulate matter like PM10 and PM2.5, the Commission proposed a revision of the Ambient Air Quality Directive (AAQD) in October 2022. This proposal aimed to incorporate UFPs into the air quality framework, reflecting the growing evidence of their significant health impacts (European Commission, 2023).

  • Specific Measures and Standards for UFPs
    In October 2024, the European Parliament and Council adopted the revised Ambient Air Quality Directive (AAQD), which mandates stricter monitoring requirements for ultrafine particles (UFPs) and other pollutants. These revisions include minimum sampling points based on population size, with at least one fixed sampling point per 5 million inhabitants at locations where high UFP concentrations are likely to occur (Council of the European Union, 2024; AAQD National Statements, 2024).
  • Rationale for Inclusion
    The inclusion of UFPs in the revised AAQD is driven by their unique health risks and the inadequacy of current metrics to capture their presence and impact. The Commission’s proposal highlights the necessity of a more nuanced approach to air quality monitoring that considers particle number concentration and size distribution (European Parliament, 2024).

European Parliament's Role
The European Parliament played a critical role in shaping the legislation related to UFPs. During the legislative process, the Parliament proposed several amendments to the Commission’s initial proposal, focusing on enhancing the monitoring and regulation of UFPs. These amendments included more stringent monitoring requirements, such as ensuring fixed measurements of UFP size distribution at urban background locations, and regular reviews of air quality standards (European Parliament, 2024; Air Quality Directive, 2024).

  • Amendments and Proposals
  1. Enhanced Monitoring: The Parliament pushed for more stringent monitoring requirements, including fixed measurements of UFP size distribution at urban background locations. The Parliament also proposed that at least one sampling point per 1 million inhabitants be established at locations with high UFP concentrations (European Parliament, 2024)..
  2. Inclusion in Regular Reviews: The Parliament emphasized the need for UFPs to be included in regular reviews of air quality standards. This ensures that regulations remain updated with the latest scientific evidence and health guidelines (European Parliament, 2024).

European Council's Position
The European Council’s involvement has been crucial in finalizing the legislative framework for UFPs. The Council’s position reflects a balance between the scientific evidence on UFPs and the practical considerations of implementing new monitoring and regulatory standards across Member States (Council of the European Union, 2024).

Current Status of the Legislation

Stricter Standards and Recent Developments
The October 2024 agreement between the European Parliament and Council entails stricter standards for several pollutants, including ultrafine particles (UFPs). This focus on UFPs is driven by their significant health impacts and the inadequacy of current air quality standards, which do not account for particle number concentration and size distribution (Council of the European Union, 2024; Air Quality Directive, 2024).

  • Minimum Number of Sampling Points at Hot Spots:
  1. At least one sampling point per 5 million inhabitants is required at locations where high UFP concentrations are likely to occur. Member States with fewer than 5 million inhabitants must establish at least one fixed sampling point at such hotspots (Council of the European Union, 2024; AAQD National Statements, 2024).
  2. Sampling points for UFPs must coincide, where appropriate, with those for particulate matter or nitrogen dioxide, and be sited in accordance with Annex VII (European Commission, 2023).
  3. Monitoring supersites in urban or rural background locations established under Article 10 do not count toward the minimum number of sampling points for UFPs if the Member State has more than 2 million inhabitants (European Parliament, 2024).
  • Supersites
  1. Member States are required to establish monitoring "Supersites" that combine multiple sampling points to collect long-term data on pollutants, including UFPs. At least one supersite must be established per 10 million inhabitants in an urban background site, and per 100,000 km² in a rural background location (European Commission, 2023).
  2. These supersites must include fixed measurements of UFP size distribution at all urban background locations to ensure that data represents the highest exposure levels (European Parliament, 2024).
  • Regular Reviews
  1. ​​​​​​​The directive mandates regular reviews to ensure that EU standards remain adequate for protecting health and the environment. These reviews will assess the need to include additional pollutants and update standards based on the latest scientific information (Council of the European Union, 2024).
  2. Frequency of Reviews: Standards will be reviewed at least every five years, ensuring that they reflect the latest scientific knowledge and health guidelines (Council of the European Union, 2024).
  3. Scope of Reviews: These reviews will assess the effectiveness of current standards in protecting public health and the environment, consider the inclusion of emerging pollutants, and adjust limits and monitoring requirements as necessary (European Parliament, 2024).

Detailed Legislative Requirements
Recent legislative developments emphasize the importance of monitoring pollutants of emerging concern, such as ultrafine particles (UFPs), black carbon, elemental carbon, ammonia, and the oxidative potential of particulate matter. This approach supports scientific understanding of their effects on health and the environment, aligning with WHO recommendations (WHO, 2021).

  • Definitions: UFPs are defined as particles with a diameter less than or equal to 100 nm, measured as the particle number concentration per cubic centimeter (cm³) for a size range with a lower limit of 10 nm and no restriction on the upper limit (Council of the European Union, 2024).
  • Sampling Points: Member States are required to monitor UFP levels in accordance with Annex III and Section 3 of Annex VII. Monitoring of black carbon concentrations may also be undertaken at the same locations. The minimum number of sampling points for fixed measurements of UFPs at hotspots is specified to ensure adequate coverage (European Commission, 2023).
  • Article 10 – Supersites: A Member State may choose not to measure black carbon, UFPs, or ammonia in half of its rural background monitoring supersites if the number of these rural background supersites exceeds the number of urban background supersites by at least a ratio of 2:1, provided that the selection of sites is representative of the three pollutants (European Parliament, 2024).
  • Annex III – Minimum Number of Sampling Points: UFPs must be monitored at selected locations alongside other air pollutants. Sampling points for UFPs should coincide, where appropriate, with those for particulate matter or nitrogen dioxide, and be sited in accordance with Annex VII. For Member States with fewer than 5 million inhabitants, at least one fixed sampling point for UFPs must be established at locations with high UFP concentrations (Council of the European Union, 2024).
  • Annex IV – Reference Methods: Reference methods for sampling and measuring UFPs, black carbon, ammonia, and the oxidative potential of particulate matter are outlined. In the absence of a European Committee for Standardization (CEN) standard method, Member States may choose appropriate methods according to Annex V, considering the measurement objectives (European Commission, 2023).
  • Annex VII – Supersites: Supersites must be located at areas with high UFP concentrations, influenced by sources such as airports, ports, roads, industrial sites, or domestic heating. Sampling points must be downwind from the main sources within the predominant wind direction, in accordance with Annex IV and V (European Parliament, 2024).

Next Steps and TimelineThe next steps involve the transposition of the directive into national law by Member States. The timeline for this process includes:

  • 2024: Provisional agreement reached and formal adoption by European Parliament and Council (Council of the European Union, 2024).
  • 2025-2027: Member States begin transposing the directive into national law, establishing monitoring infrastructure.
  • 2028: Review of initial implementation and adjustments based on preliminary data.
  • 2030: Full implementation of monitoring systems and compliance with new standards (Council of the European Union, 2024).

Conclusion

The October 2024 revision of the Ambient Air Quality Directive (AAQD) marks a significant step forward in the regulation of ultrafine particles (UFPs) in Europe. The directive addresses key gaps in air quality monitoring by incorporating UFPs and setting strict standards for their measurement, alongside black carbon, elemental carbon, ammonia, and the oxidative potential of particulate matter. The inclusion of these pollutants reflects a growing understanding of their serious health impacts and the need for targeted regulations.
However, the successful implementation of the revised directive will depend on Member States' ability to meet the timeline and infrastructure requirements. Some countries have raised valid concerns about the cost and practicality of the new monitoring systems, particularly in areas with lower incomes or higher reliance on older technologies.
The directive’s phased approach, with its 2030 compliance deadline and periodic reviews, provides flexibility while ensuring that air quality standards evolve with the latest scientific findings. By 2030, the EU aims to have comprehensive data on UFPs, helping protect public health and guiding future legislative actions (Council of the European Union, 2024).
With continued collaboration between the European Commission, Member States, and scientific bodies, Europe is moving toward a future where the risks of UFP exposure are better understood, monitored, and mitigated, ultimately contributing to the overall health and well-being of its citizens (European Parliament, 2024).
Get in touch
Find out more

References